Urovalve, Inc. has developed and patented technology to control fluid flow through small diameter flexible tubing. The core proprietary technology for the Surinate^® Bladder Management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate^® wearer who uses a hand held magnet to self-regulate flow. Currently available devices require continuous bladder drainage or insertion of a tube into the urethra several times each day. The Surinate^® Bladder Management system provides a solution to the problems of life style, urinary tract infections, and substantial healthcare worker expenses associated with existing catheters. The company successfully completed a clinical feasibility study, which demonstrated that the α-version of the Surinate^® Bladder Management system remained in place for 24 hours after insertion (even with rigorous exercise), the valve worked reliably and the system could be easily withdrawn without causing damage to the urethra. Based upon these results and previous laboratory studies, the Company conducted a thorough review and developed the β-version to improve the ease of insertion, make the valve easier for the patient to operate without assistance, and to increase flow rate, thereby reducing the time necessary for bladder emptying. The Company currently is working to complete laboratory and clinical testing of the β-version.